Pancreatic Cancer Research

ResearcherJinhua Central HospitalActive in the last 2 years

Yilan Ma

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0009-0008-5381-7635; OpenAlex author ID A5083996085.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. The effect of CD40 agonist antibody therapy on the pancreatic cancer microenvironment. First author DOI 10.1007/s00210-025-04532-x↗
  2. Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer. Co-author DOI 10.1186/s12935-020-01370-0↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Yanping Chen · 1 shared paper, 2026
  2. Zheng Liu · 1 shared paper, 2020
  3. Xiao Jin · 1 shared paper, 2020

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.